Purpose: To determine the efficacy of a small molecule inhibitor of α4 integrin (CT301) at reversing the clinical, pathological and MR- detectable deficits associated with the acute phase of experimental allergic encephalomyelitis (EAE). Materials and methods: EAE was induced in 36 female Hartley guinea pigs, and the treatment period was from day 11 to day 17 post-immunization. Animals received either saline (n=12), anti-α4 integrin antibody (AN100226m; n=12) or CT301 (n=12). T2-weighted fast spin echo and T1-weighted pre- and post-contrast scans were performed at the beginning (day 11) and end (day 18) of the treatment period, and scored for cerebral inflammation and gadolinium enhancement. T1-weighted images were further analyzed to quantify this enhancement as a measure of blood-brain barrier integrity. Dissected CNS was evaluated for inflammation and demyelination. Results: CT301 successfully reversed two clinical indicators of disease over the course of the treatment period. These animals showed decreased T2-weighted abnormalities, as well as a reduction in gadolinium leakage on T1-weighted images. Meningeal and perivascular inflammation was decreased by anti-α4 integrin treatments. Conclusion: CT301 effectively reverses the clinical, pathological and MR-detectable deficits of acute EAE, and may therefore be a promising therapeutic agent in multiple sclerosis (MS).
Filippi M , Grossman RI.MRI techniques to monitor MS evolution: the present and the future . Neurology2002; 58: 1147-1153 .
2.
Filippi M , Falini A , Arnold DL , Fazekas F , Gonen O , Simon JHet al.Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group . J Magn Reson Imaging2005; 21: 669-675 .
3.
Miller DH , Filippi M , Fazekas F , Frederiksen JL , Matthews PM , Montalban Xet al.Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis . Ann Neurol2004; 56: 273-278 .
4.
O’Riordan JI , Thompson AJ , Kingsley DP , MacManus DG , Kendall BE , Rudge Pet al.The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up . Brain1998; 121: 495-503 .
5.
Lassmann H , Wekerle H.Experimental models of multiple sclerosis. In Compston A , Ebers G , Lassmann H , McDonald I , Matthews B , Wekerle H eds. McAlpine’s multiple sclerosis. London: Churchill Livingstone , 1998: 409-433.
6.
Hawkins CP , MacKenzie F , Tofts P , du Boulay EP , McDonald WI.Patterns of blood-brain barrier breakdown in inflamma-tory demyelination . Brain1991; 114: 801-810 .
7.
Namer IJ , Steibel J , Poulet P , Armspach JP , Mohr M , Mauss Yet al.Blood-brain barrier breakdown in MBP-specific T cell induced experimental allergic encephalomyelitis. A quantitative in vivo MRI study . Brain1993; 116: 147-159 .
8.
Seeldrayers PA , Syha J , Morrissey SP , Stodal H , Vass K , Jung Set al.Magnetic resonance imaging investigation of blood-brain barrier damage in adoptive transfer experimental auto-immune encephalomyelitis . J Neuroimmunol1993; 46: 199-206 .
9.
Karlik SJ , Grant EA , Lee D , Noseworthy JH.Gadolinium enhancement in acute and chronic-progressive experimental allergic encephalomyelitis in the guinea pig . Magn Reson Med1993; 30: 326-331 .
10.
Namer IJ , Steibel J , Piddlesden SJ , Mohr M , Poulet P , Chambron J.Magnetic resonance imaging of an antibody-mediated demyelinating experimental allergic encephalomyelitis . J Neuroimmunol1994; 54: 41-50 .
11.
Morrissey SP , Stodal H , Zettl U , Simonis C , Jung S , Kiefer Ret al.in vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema . Brain1996; 119: 239-248 .
12.
Karlik SJ , Munoz D , St Louis J , Strejan G.Correlation between MRI and clinico-pathological manifestations in Lewis rats protected from experimental allergic encephalomyelitis by acylated synthetic peptide of myelin basic protein . Magn Reson Imaging1999; 17: 731-737 .
13.
Juhler M , Barry DI , Offner H , Konat G , Klinken L , Paulson OB.Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat . Brain Res1984; 302: 347-355 .
14.
Hawkins CP , Munro PM , MacKenzie F , Kesselring J , Tofts PS , du Boulay EPet al.Duration and selectivity of blood-brain barrier breakdown in chronic-relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers . Brain1990; 113: 356-378 .
15.
Grossman RI , Lisak RP , Macchi PJ , Joseph PM.MR of acute experimental allergic encephalomyelitis . AJNR Am J Neuroradiol1987; 8: 1045-1048 .
16.
t’Hart BA , Bauer J , Muller HJ , Melchers B , Nicolay K , Brok Het al.Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus) . Am J Pathol1998; 153: 649-663 .
17.
Kuharik MA , Edwards MK , Farlow MR , Becker GJ , Azzarelli B , Klatte ECet al.Gd-enhanced MR imaging of acute and chronic experimental demyelinating lesions . AJNR Am J Neuroradiol1988; 9: 643-648 .
18.
Yednock TA , Cannon C , Fritz LC , Sanchez-Madrid F , Steinman L , Karin N.Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin . Nature1992; 356: 63-66 .
19.
Baron JL , Madri JA , Ruddle NH , Hashim G , Janeway CA Jr.Surface expression of alpha 4 integrin by CD4 cells is required for their entry into brain parenchyma . J Exp Med1993; 177: 57-68 .
20.
Soilu-Hanninen M , Roytta M , Salmi A , Salonen R.Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis . J Neuroimmunol1997; 72: 95-105 .
21.
Brocke S , Piercy C , Steinman L , Weissman IL , Veromaa T.Antibodies to CD44 and integrin α4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment . PNAS1999; 96: 6896-6901 .
22.
Kent SJ , Karlik SJ , Rice GP , Horner HC.A monoclonal antibody to α4 integrin reverses the MR-detectable signs of experimental allergic encephalomyelitis in the guinea pig . J Magn Reson Imaging1995; 5: 535-540 .
23.
Kent SJ , Karlik SJ , Cannon C , Hines DK , Yednock TA , Fritz LCet al.A monoclonal antibody to α4 integrin suppresses and reverses active experimental allergic encephalomyelitis . J Neuroimmunol1995; 58: 1-10 .
24.
Keszthelyi E , Karlik S , Hyduk S , Rice GP , Gordon G , Yednock Tet al.Evidence for a prolonged role of α4 integrin throughout active experimental allergic encephalomyelitis . Neurology1996; 47: 1053-1059 .
25.
Leger OJ , Yednock TA , Tanner L , Horner HC , Hines DK , Keen Set al.Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis . Hum Antibodies1997; 8: 3-16 .
26.
Tubridy N , Behan PO , Capildeo R , Chaudhuri A , Forbes R , Hawkins CPet al.The effect of anti-α4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group . Neurology1999; 53: 466-472 .
27.
Miller DH , Khan OA , Sheremata WA , Blumhardt LD , Rice GP , Libonati MAet al.A controlled trial of Natalizumab for relapsing multiple sclerosis . N Engl J Med2003; 348: 15-23 .
Kuchroo VK , Martin CA , Greer JM , Ju ST , Sobel RA , Dorf ME.Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis . J Immunol1993; 151: 4371-4382 .
30.
Engelhardt B , Laschinger M , Schulz M , Samulowitz U , Vestweber D , Hoch G.The development of experimental autoimmune encephalomyelitis in the mouse requires α4-integrin but not α4β7-integrin . J Clin Invest1998; 102: 2096-2105 .
31.
van der Laan LJ , van der Goes A , Wauben MH , Ruuls SR , Dopp EA , De Groot CJet al.Beneficial effect of modified peptide inhibitor of α4 integrins on experimental allergic encephalomyelitis in Lewis rats . J Neurosci Res2002; 67: 191-199 .
32.
Piraino PS , Yednock TA , Freedman SB , Messersmith EK , Pleiss MA , Vandevert Cet al.Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of α4 integrin . J Neuroimmunol2002; 131: 147-159 .
33.
Bastianello S , Pozzilli C , Bernardi S , Bozzao L , Fantozzi LM , Buttinelli Cet al.Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis . Neurology1990; 40: 591-595 .
34.
Kermode AG , Thompson AJ , Tofts P , MacManus DG , Kendall BE , Kingsley DPet al.Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications . Brain1990; 113: 1477-1489 .
